Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-2965
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study ; volume:26 ; number:1 ; day:19 ; month:9 ; year:2014 ; pages:361-372 ; date:1.2015
Osteoporosis international ; 26, Heft 1 (19.9.2014), 361-372, 1.2015
- Urheber
-
Silverman, S. L.
Siris, E.
Kendler, D. L.
Belazi, D.
Brown, J. P.
Gold, D. T.
Lewiecki, E. M.
Papaioannou, A.
Simonelli, C.
Ferreira, I.
Balasubramanian, A.
Dakin, P.
Ho, P.
Siddhanti, S.
Stolshek, B.
Recknor, C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00198-014-2871-6
- URN
-
urn:nbn:de:101:1-2019063020081418642357
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Silverman, S. L.
- Siris, E.
- Kendler, D. L.
- Belazi, D.
- Brown, J. P.
- Gold, D. T.
- Lewiecki, E. M.
- Papaioannou, A.
- Simonelli, C.
- Ferreira, I.
- Balasubramanian, A.
- Dakin, P.
- Ho, P.
- Siddhanti, S.
- Stolshek, B.
- Recknor, C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Factors associated with high 24-month persistence with denosumab : results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
Postmenopausal osteoporosis
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
Treatment of osteoporosis with denosumab in patients with decreased kidney function
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Factors associated with high 24-month persistence with denosumab : results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
Postmenopausal osteoporosis
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
Treatment of osteoporosis with denosumab in patients with decreased kidney function
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Factors associated with high 24-month persistence with denosumab : results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
Postmenopausal osteoporosis
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
Treatment of osteoporosis with denosumab in patients with decreased kidney function
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab